2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Multiple Myeloma: Should We Consider Idecabtagene Vicleucel, Anti-BCMA CAR-T Therapy, Effective in Heavily Pretreated R/R MM?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jakub Svoboda
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Jakub Svoboda
Login to view comments.
Click here to Login
